Aminoglycosides and renal magnesium homeostasis in humans

Nephrology Dialysis Transplantation

Volumn 15, Issue 6, 2000, Pages 822-826

  Von Vigier, Rodo O ^a   Truttmann, Anita C ^a   Zindler Schmocker, Karin ^a   Bettinelli, Alberto ^a   Aebischer, Carmen Casaulta ^a   Wermuth, Bendicht ^a   Bianchetti, Mario G ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Aminoglycosides; Cystic fibrosis; Kidney disease; Magnesium; Magnesium deficiency

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; CALCIUM; CEFTAZIDIME; CREATININE; ELECTROLYTE; MAGNESIUM; POTASSIUM; SODIUM; UREA;

ADOLESCENT; ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CHILD; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CYSTIC FIBROSIS; FEMALE; HOMEOSTASIS; HUMAN; HYPOMAGNESEMIA; INFANT; LUNG INFECTION; MAGNESIUM URINE LEVEL; MALE; POTASSIUM BLOOD LEVEL; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; UREA BLOOD LEVEL;

EID: 0034073863     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.6.822     Document Type: Article

References (30)

1. Werner CA, Tompsett R, Muschenheim G, McDermott W. The toxicity of viomycin in humans. Am Rev Tubercle 1951; 63: 49-61
2. Bar RS, Wilson HE, Mazzaferri EL. Hypomagnesemic hypocalcemia secondary to renal magnesium wasting: a possible consequence of high-dose gentamicin therapy. Ann Intern Med 1975; 82: 646-649
3. Kelnar CJH, Taor WS, Reynolds DJ, Smith DR, Slavin BM, Brook CGD. Hypomagnesaemic hypocalcaemia with hypokalaemia caused by treatment with high dose gentamicin. Arch Dis Child 1978; 53: 817-820
4. Wilkinson R, Lucas GL, Heath DA, Franklin IM, Boughton BJ. Hypomagnesaemic tetany associated with prolonged treatment with aminoglycosides. Br Med J 1986; 292: 818-819
5. Adams JP, Conway SP, Wilson C. Hypomagnesaemic tetany associated with repeated courses of intravenous tobramycin in a patient with cystic fibrosis. Respir Med 1988; 92: 602-604
6. Foster JE, Harpur ES, Garland HO. An investigation of the acute effect of gentamicin on the renal handling of electrolytes in the rat. J Pharmacol Exp Ther 1992; 261: 38-43
7. Garland HO, Birdsey TJ, Davidge CG et al. Effects of gentamicin, neomycin and tobramycin on renal calcium and magnesium handling in two rat strains. Clin Exp Pharmacol Physiol 1994; 21: 109-115
8. Parson PP, Garland HO, Harpur ES, Old S. Acute gentamicin-induced hypercalciuria and hypermagnesiuria in the rat: dose-response relationship and role of renal tubular injury. Br J Pharmacol 1997; 122: 570-576
9. Whang R. Clinical disorders of magnesium metabolism. Compr Ther 1997; 23: 168-173
10. Truttmann AC, Bettinelli A, Bianchetti MG. Métabolisme du magnésium pour le clinicien: une mise au point actuelle et simple. Med Hyg 1997; 55: 551-553
11. Morger ID, Truttmann AC, von Vigier RO, Bettinelli A, Ramelli GP, Bianchetti MG. Plasma and ionized magnesium in tubular disorders with and without total hypomagnesemia. Pediatr Nephrol 1999; 13: 50-53
12. Saha H, Harmoinen A, Nisula M, Pasternack A. Serum ionized versus total magnesium in patients with chronic renal disease. Nephron 1998; 80: 149-152
13. Schaad UB, Wedgwood-Krucko J, Suter S, Kraemer R. Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis. J Pediatr 1987; 111: 599-605
14. Fiel SB. Clinical management of pulmonary disease in cystic fibrosis. Lancet 1993; 341: 1070-1074
15. Mann CK, Yoe JH. Spectrophotometric determination of magnesium with sodium 1-azo-2-hydroxy-3-(2,4-dimethyl-carboxanilido)-naphthalene-1'-(2 hydroxybenzene-5-sulfonate). Anal Chem 1956; 28: 202-205
16. Noto A, Ogawa Y, Mori S et al. Simple, rapid spectrophotometric assay for urinary N-acetyl-β-D glucosaminidase, with use of a new chromogenic substrate. Clin Chem 1983; 29, 1713-1716
17. Brodhel J, Krause A, Hover PF. Assessment of maximal tubular phosphate reabsorption: comparison of direct measurement with the nomogram of Bijvoet. Pediatr Nephrol 1988; 2: 183-189
18. Rodriguez-Soriano J, Ubetagoyena M, Vallo A. Transtubular potassium concentration gradient: a useful test to estimate renal aldosterone bio-activity in infants and children. Pediatr Nephrol 1990; 4: 105-110
19. de Rouffignac C. Renal magnesium handling. Adv Nephrol Necker Hasp 1997; 27: 317-342
20. Kelepouris K, Agus ZS. Hypomagnesemia: renal magnesium handling. Semin Nephrol 1998; 18: 58-73
21. Swan SK. Aminoglycoside ncphrotoxicity. Semin Nephrol 1997; 17: 27-33
22. Dhingra S, Solven F, Wilson A, McCarthy DS. Hypomagnesemia and respiratory muscle power. Am Rev Respir Dis 1984; 129: 497-498
23. Dodge JA. Gastrointestinal tract and nutrition in cystic fibrosis: pathophysiology. J R Soc Med 1986; 79 [Suppl 12]: 27-31
24. Reisman J, Petrou C, Corey M, Stringer D, Durie P, Levison H. Hypoalbuminemia at initial presentation in patients with cystic fibrosis. J Pediatr 1989; 115: 755-758
25. Abman SH, Accurso FJ, Sokol RJ. Hypoalbuminemia in young infants with cystic fibrosis. J Pediatr 1990; 116: 840-841
26. Baldree LA, Stapleton FB. Uric acid metabolism in children. Pediatr Clin North Am 1990; 37: 391-418
27. Blumer JL, Stern RC, Klinger JD et al. Ceftazidime therapy in patients with cystic fibrosis and multiply-drug-resistant Pseudomonas. Am J Med 1985; 79 [Suppl. 2A]: 37-46
28. Moellering RC. Ceftazidime: a new broad spectrum cephalosporin. Pediatr Infect Dis J 1990; 4: 390-393
29. Hügh R, Artho G, Wiesmann UN, Peheim E, Schaad UB, Bianchetti MG. Untersuchung der Nephrotoxizität von Amikacin bei Patienten mit zystischer Fibrose. Schweiz Med Wochenschr 1992; 122: 930-935
30. Wong V, Goodenough DA. Paracellular channels! Science 1999; 285: 62